Supplementary Figure S1

Supplementary Figure S1

Supplementary FigureS1 G E C A Cancer Cell Fraction (%) Cancer Cell Fraction (%) Cancer Cell Fraction (%) 100% 100% 100% 20% 40% 60% 80% Cancer Cell Fraction (%) 20% 40% 60% 80% 20% 40% 60% 80% 100% 0% 0% 0% 20% 40% 60% 80% 0% 1DCIS-A 6ILC 8ILC 3DCIS 8LCIS-A 1DCIS-B 6LCIS-A 1DCIS−A 1DCIS−B 1LCIS−A 1LCIS−B 3IDC Cluster: 3DCIS 3LCIS (0.67) (0.68) 3IDC (0) (0) 8LCIS-B 1LCIS-A 6LCIS−A 6LCIS−B 8LCIS−A 8LCIS−B 6LCIS-B 4 SPAST (p.E602Q) Cluster: 4 4 TRIM63 (p.P120T) (0.69) (0.78) 6ILC 4 TULP1 (p.A114V) 3LCIS (0) 8ILC 4 CYB5R3 (p.P319R) Cluster: 5 5 TBX3 (p.R436Tfs*3) 5 DYSF (p.F205Sfs*35) Cluster: 1LCIS-B 5 DYSF (p.A214Lfs*45) (0.69) 2 ABL1 (p.P810L) (0) (0) (0.57) (0.59) 2 ANP32B (p.G237S) 2 ACKR2 (p.L85V) (0) 2 AHR (p.Q600E) 2 ANKRD34B (p.T302A) 2 C11orf1 (p.Y53C) 2 ART1 (p.R179Q) 4 ZNF484 (p.T708I) 2 ATRNL1 (p.I390V) 2 CBFB (p.X55_splice) 2 B4GALT2 (p.V207I) 1 ABCA3 (p.C1337Y) 4 4 AKT1 (p.L52R) 2 BBS9 (p.Q621*) 2 BBX (p.N563I) 2 BLACE (p.E153K) 1 ACAN (p.V1839L) 4 VPS13A (p.A2948T) 2 2 COPG1 (p.I92V) 2 BLK (p.A71T) 1 CDH1 (p.X571_splice) 4 ZNF426 (p.I297S) 2 C11orf35 (p.C345S) 2 LDB3 (p.R31Q) 2 C11orf35 (p.G207R) 1 EIF4E2 (p.R103C) 2 C2orf62 (p.A382V) 1 ATRX (p.T2295I) 2 C2orf62 (p.S384W) 2 PPAP2B (p.S254N) 2 C3orf35 (p.M1?) 1 FOXK2 (p.H308R) 1 COX8A (p.H61Y) 2 CA2 (p.Q74*) 2 SPEN (p.P677Lfs*132) 2 CCDC154 (p.I612M) 1 HDAC6 (p.T979I) 1 DNAH9 (p.R1533W) 2 CCDC64B (p.E240Q) 2 CEP290 (p.I2134T) 1 ITGAV (p.R152L) 2 CFHR5 (p.V379L) 1 G3BP2 (p.E279K) 2 WIZ (p.R100W) 2 CLIC6 (p.S269G) 1 KRTAP19−4 (p.G40R) 2 DAXX (p.A486G) 1 1 OGDHL (p.V304A) 4 TCF7L2 (p.G308Sfs*16) 2 DISC1 (p.E751Q) 1 LAMA5 (p.R2226Pfs*3) 2 DNAH12 (p.L2346F) 1 PDE10A (p.M460T) 2 DUPD1 (p.E25K) 1 4 GATA3 (p.R366*) 1 LMO7 (p.G1160E) 2 EPC2 (p.R510T) 1 PRR11 (p.E23Rfs*46) 2 ERAP2 (p.R751C) 1 LTBP2 (p.K392T) 4 GLUD2 (p.R76H) 2 FAM161B (p.P688S) 2 FAM47A (p.E507Q) 1 SERPINA3 (p.M290L) 7 2 FNDC3A (p.E360K) 1 RBM10 (p.S622L) 4 BCL11B (p.T435I) 1DCIS−B 2 FUT7 (p.A270T) 1LCIS−B 1 SERPINA3 (p.M290K) 4 2 GATA1 (p.R113H) 1 SLC17A6 (p.E339K) 1LCIS−A 2 GPIHBP1 (p.S144F) 1 SYNM (p.R1092C) 4 FAM149A (p.L332I) 2 GSTO2 (p.M29I) 5 1 SOGA2 (p.N219S) 2 HIST1H4L (p.G10D) 1 TNFRSF8 (p.Q202K) 4 FAM174A (p.A31V) 2 HMCN1 (p.V3540I) 1 WDR3 (p.P804H) 2 HP1BP3 (p.I516L) 2 ICT1 (p.R8L) 1 YY1AP1 (p.G107E) 1 WWP2 (p.N592K) 4 KLHL26 (p.S179L) 7 2 IGLV1−50 (p.N74S) 1 2 KIFC1 (p.R219Q) D 3 CDH1 (p.P127Afs*41) 6 7 2 KIRREL3 (p.I190V) C 1 ZYX (p.Q233L) 2 KRT75 (p.R527Q) 4 MACF1 (p.X4015_splice) L I C 3 ANKRD11 (p.R840Q) S 2 LCE2B (p.I51S) 4 C1orf173 (p.E749K) 2 I 6ILC 2 LEMD3 (p.S164L) 1 S 4 SAG (p.R179C) B 6 2 LRRIQ1 (p.N1702Ifs*20) 3 ARHGAP11A (p.V410I) 4 C2CD5 (p.D67V) B 2 MALRD1 (p.D1091G) L 2 MASP2 (p.D120G) 3 CABIN1 (p.D1749N) 3 BTRC (p.L389Ffs*5) C 4 FRMD3 (p.G200W) 2 MATN4 (p.P508L) I p.X55_splice S 2 MESP2 (p.H241Y) 4 4 HSCB (p.M157T) 3 CASQ1 (p.M87T) 2 MSLNL (p.E702Q) 3 GK2 (p.N92S) A 2 MUC7 (p.L249P) 4 NPFFR2 (p.P214S) 1 3 CEP68 (p.F367Y) 2 MUTYH (p.R171W) 3 3 MAPK8IP2 (p.G227S) 2 NEB (p.E1469D) I 3 DCPS (p.R315H) 2 NID1 (p.R757H) 4 PGBD2 (p.E53*) L 1 2 NOS3 (p.E463D) C 5 3 PEF1 (p.L179V) 2 NRXN3 (p.S184L) 3 DNAJC30 (p.P14L) 4 WEE2 (p.D48V) 6LCIS−B 2 OR5AR1 (p.I225V) 3 SPEN (p.L2247Cfs*106) 2 OR5AS1 (p.D191N) 4 ZNF229 (p.T211S) 3 HLA−DMA (p.G181A) 2 OR6T1 (p.I36T) 3 2 PCDHGA10 (p.E257Q) 2 BCL11A (p.P480L) 3 OR10J3 (p.V205I) 3 TFEC (p.P10S) 2 PCDHGA8 (p.E316Q) 2 PHKB (p.M185I) 2 DNAH17 (p.E2368K) 3 OR52J3 (p.R224C) 2 PIK3C2G (p.A1360V) 3 VKORC1L1 (p.R8S) 2 PKP4 (p.D604G) 3 2 2 PTCH1 (p.T1195S) 2 GAS7 (p.A323V) 3 PGM2 (p.V102M) 3LCIS 2 2 3 AKR1C4 (p.G298V) 2 PTPRC (p.I296L) 8LCIS−B 2 MID1 (p.Y542F) 2 RASGRF1 (p.R478C) 8LCIS−A 3 SCLT1 (p.D104E) 3IDC 2 RNLS (p.M308I) 2 2 RPRM (p.E43K) 2 PYDC2 (p.D48E) 1 3 ATP8A1 (p.I306V) 3 SLC9A5 (p.K642M) 2 SBK1 (p.L32V) 2 5 L 2 SH3RF3 (p.A35T) 2 RREB1 (p.E1498G) C 3 NAP1L5 (p.A22V) 2 SH3TC1 (p.L1016V) L 3 SPEG (p.R1340Q) C 1DCIS−A I 2 SMG1 (p.R1418T) S I 3 ARHGEF12 (p.R705H) 3DCIS 2 SNED1 (p.R129Q) S 6LCIS−A 3 TCP11L2 (p.D261N) 3 SENP6 (p.S606R) 2 SNRNP70 (p.R356Q) 1 B 8 8ILC 3 C11orf35 (p.R141W) NCOR1 2 SORL1 (p.E270K) 3 TMEM108 (p.A255V) 2 SPIC (p.K109R) 1 L 1 1 CBFB (p.X133_splice) 9 2 SPTAN1 (p.D1676H) 3 CASD1 (p.F17L) C 0 1q3 TMEM42gain (p.M96V) 2 ST6GAL2 (p.F30Y) I L 8 S 2 TAF1C (p.G635S) GATA3,HMCN1 C I 3 CXorf66 (p.N244D) 1 CDH1 (p.Y413Ifs*6) D L I A 3 TRBV4−1 (p.Y54*) 2 TBX22 (p.N368H) S C 3 DNAH9 (p.T3487M) C 2 TELO2 (p.A11T) 1q gain, 16q loss I TBX3 1 CEBPA (p.G255E) B S 2 TELO2 (p.A11D) 7 3 TTN (p.P15979L) 3 2 TENM1 (p.G344S) A 3 DTHD1 (p.E725Q) 2 TLX1 (p.G31D) 3 ZNF541 (p.G296W) 1 ELP2 (p.Q500Rfs*7) D 1q gain 2 TNXB (p.T1916A) 3 DYTN (p.F565S) C 2 TRMT10B (p.G186E) I 3 ZNF561 (p.K22T) 1 GATAD2A (p.K367R) S 2 USP29 (p.E400Q) CDH1 p.L731Gfs*38 , 3 EFTUD2 (p.R730H) 2 ZBTB7C (p.V353G) A 2 AP3B1 (p.S855C) 2 ZIM3 (p.K438*) NCOR1 ,CBFB 3 FPR3 (p.C126F) 2 ZNF182 (p.H592Y) 1 1 GNAT2 (p.R105Q) 1 5 2 ATP2B2 (p.D518N) 6 2 ZNF467 (p.E567K) 1q gain, 16q loss 3 COG4 (p.N345T) 3 GUSB (p.A380T) I 3 D L 1q gain 1 GRSF1 (p.I341S) 3 HELZ2 (p.V1034M) C 2 B3GALNT1 (p.G109V) 3 HRH2 (p.A209T) C 3 MYH1 (p.V140L) 3 ZCCHC5 (p.R19W) I 1 HMGCS2 (p.R188H) 3 KIAA1462 (p.A1045V) TBX3 2 CBFB (p.X55_splice) S 3 WFIKKN2 (p.K107R) 3 8 CATSPER1 (p.T628M) 1 3 LSAMP (p.P131Q) 2 CDH1 (p.G690fs) 1 HYAL2 (p.D133N) 8 DFNA5 (p.G59D) 1q gain 8 DNAH8 (p.R1977K) 2 DHX15 (p.E208*) 8 GHRHR (p.I387F) 3 MUC16 (p.S13209N) 1 IGDCC3 (p.M348T) 8 GPR143 (p.C316Y) Cancer CellFraction(%) Cancer CellFraction(%) Cancer CellFraction(%) Cancer CellFraction(%) 8 HS3ST6 (p.K239R) 3 NBPF20 (p.F69C) 2 DVL3 (p.P22R) 8 8 KRT8 (p.S59A) ,GATA3,HMCN1 1 INTS2 (p.Q123H) 8 LMO4 (p.C50G) 80% <CCF100% 60% <CCF<=80% 40% <CCF<=60% 20% <CCF<=40% 10% <CCF<=20% 0% <CCF<=10% CCF =0% 80% <CCF100% 60% <CCF<=80% 40% <CCF<=60% 20% <CCF<=40% 10% <CCF<=20% 0% <CCF<=10% CCF =0% 80% <CCF100% 60% <CCF<=80% 40% <CCF<=60% 20% <CCF<=40% 10% <CCF<=20% 0% <CCF<=10% CCF =0% 3 NUP214 (p.L59F) 2 IDH3G (p.P67S) 80% <CCF100% 60% <CCF<=80% 40% <CCF<=60% 20% <CCF<=40% 10% <CCF<=20% 0% <CCF<=10% CCF =0% 8 SZT2 (p.F1400L) 1q gain, 16q loss 8 TEX13A (p.P150T) 2 1 KDM6A (p.R658*) 3 OR2L2 (p.T105I) 2 MPRIP (p.R67Q) 8 TTN (p.V27187I) 8 EPHB1 (p.I330T) CDH1 p.L731Gfs*38 , ,CBFB 3 PABPC3 (p.F335Lfs*19) 2 MVD (p.G365D) 1 MADD (p.W250C) 8 TSPYL2 (p.R13H) 1 C7orf57 (p.R231*) 1q gain, 16q loss 3 RGMB (p.D103Y) 2 QARS (p.L252P) 1 CDK3 (p.D38N) 1 MRGPRF (p.G63R) 1 DDX11 (p.S561F) 1 FETUB (p.M106I) 3 SPATS2 (p.Y437S) 2 RABGAP1L (p.A306T) 1 FIZ1 (p.S117F) 1 OSGIN1 (p.A11T) 1 1 FREM2 (p.V1876I) 3 TOPBP1 (p.C76Y) 2 SPDEF (p.P321L) 1 HLA−DRB5 (p.R77Q) 1 OVCH1 (p.S688R) 1 LPCAT4 (p.L213I) 3 ZDBF2 (p.R291C) 2 ST5 (p.I889V) 1 NCOR1 (p.L57Afs*23) 1 PRSS1 (p.N246D) 1 TNNT3 (p.R63H) 1 PRSS3 (p.R158Sfs*11) 2 ZNF281 (p.E640G) 1 PRSS3 (p.T160Sfs*4) H F D Cancer Cell Fraction (%) B 100% Cancer Cell Fraction (%) Cancer Cell Fraction (%) 20% 40% 60% 80% 0% 100% 100% Cancer Cell Fraction (%) 20% 40% 60% 80% 20% 40% 60% 80% 100% 0% 20% 40% 60% 80% 0% 0% 5ILC 9IDC 7DCIS 2ILC CDH1,ELF3, ARID1A,ASXL1,NCOR1,ZNF292 TCF7L2 ,GATA3,CBFB RUNX1p.X118_splice SPENp.P677Lfs*132 1q gain, 16q loss 9LCIS-A p.I1220L p.Q264* 7IDC BTRC, GK2,SPEN p.L2247Cfs*106 1q gain, 16q loss KDM6A ,RUNX1 APC,HMCN1, KDM6A p.W1219C 2LCIS-A 5LCIS 7LCIS−A 7LCIS−B 5ILC 5LCIS 2LCIS−A 2LCIS−B 1q gain 16q loss ,CBFB p.X133_splice7DCIS Cluster: 7ILC 7IDC CDH1,CEBPA,KDM6A 7ILC (0.36) (0.59) 9LCIS-B Cluster: 2ILC ARID1A,ASXL1,NCOR1,ZNF292 Cluster: (0.65) (0.55) (0.69) 2LCIS-B (0.69) (0.65) CDH1,ELF3, ,RUNX1p.X118_splice (0.65) 2 AQPEP (p.E55K) (0.6) p.W1219C p.I1220L p.Q264* 7LCIS-A 1q gain, 16q loss APC,HMCN1, KDM6A ,KDM6A ,RUNX1 1q gain,16q loss ,CBFB p.X133_splice ,CDH1,CEBPA,KDM6A (0) 9LCIS−B 2 BAZ2B (p.Q499*) 9LCIS−A 2 C1orf177 (p.L376Yfs*3) 1 AC002472.13 (p.D116G) 2 CCDC109B (p.Q181*) 9IDC 2 CCDC84 (p.K146N) BTRC, GK2,SPEN p.L2247Cfs*106 2 CDH1 (p.X130_splice) 1 CDH1 (p.L582Cfs*2) TCF7L2 ,GATA3,CBFBp.X55_splice ,SPENp.P677Lfs*132 2 CHADL (p.G539R) 1 CBFB (p.Q67H) Cluster: 2 CHD1 (p.L1358P) 1 GPR39 (p.I15V) 2 CPA3 (p.X328_splice) 7LCIS-B 1q gain, 16q loss 1 2 DDX31 (p.R20W) (0.57) 1 KIAA1429 (p.D395G) 2 ELF3 (p.S133A) 1 CDH1 (p.L731Gfs*38) (0) (0) 2 ERCC2 (p.N238S) 1 MYH9 (p.E929dup) 2 FAM154B (p.P265S) 2 FAT2 (p.V3519I) 1 CENPJ (p.V555I) 1 SOX10 (p.S135G) 2 FBXO11 (p.D908N) 2 FRMPD1 (p.E744K) 1 ZNF473 (p.D76N) 2 GDE1 (p.S52F) 1 DFNA5 (p.S474C) 3 FSCB (p.A181V) 2 GRB10 (p.Q411*) 1 ZNF575 (p.A142T) 2 INSM1 (p.G148R) 2 ITGA10 (p.A633V) 2 AC138647.1 (p.R141C) 2 KIF21B (p.K545R) 1 KY (p.G51E) 2 3 CDH1 (p.X178_splice) 2 KRTAP4−8 (p.C95S) 3 2 ADAMTSL4 (p.L905P) 2 MGST2 (p.S15L) 2 MOXD1 (p.D105Y) 1 MAGEA11 (p.K240*) 2 ARHGAP22 (p.R57C) 2 MROH2B (p.E1109K) 3 CYP4F3 (p.R390W) 2 PGAP1 (p.E461Q) 1 2 CBFB (p.Q134*) 2 PGAP1 (p.E44K) 1 PIK3CA (p.H1047R) 2 PIK3CA (p.E545K) 2 EMILIN2 (p.G934R) 2 PPP6R3 (p.G97E) 3 TCEAL2 (p.R128H) 2 RABEP2 (p.S265L) 1 PLCE1 (p.P698S) 2 GATA3 (p.X308_splice) 2 RIBC2 (p.R132W) 2 2 RNMTL1 (p.Q74L) 2 KLHL36 (p.Q84*) 2 RUNX1 (p.X118_splice) 1 SLC44A4 (p.X377_splice) 1 ADI1 (p.X81_splice) 2 SPINT1 (p.D49N) 2 LDB3 (p.T527N) 2 SYTL4 (p.E286K) 2 TMEM156 (p.I195T) 2 LYN (p.L93Wfs*14) 2 TSPYL2 (p.E93K) 1 TOR1AIP2 (p.V418G) 1 C14orf1 (p.N73S) 2 TXNDC11 (p.M213R) C D 2 NINL (p.A859S) P 2 VPS13D (p.L4009F) H I K 2 ZFYVE26 (p.S1768P) 1 CALCRL (p.X390_splice) 1 P 2 PIK3CA (p.H1047R) 3 2 ZNF341 (p.D25Y) ,CBFB,GATA3,LYN C I P APC 3 ADNP (p.E883Q) p.Q23* A 1 C3orf67 (p.D536E) K I 1q gain,16q loss p.E545K K 3 ANKLE2 (p.S181Rfs*13) 2 TENM4 (p.D1313N) 3 1 ITPRIPL1 (p.V158I) 3 C 3 ARL5C (p.V19L) C 4 FDX1L (p.G87E) A 3 ASXL1 (p.E670Gfs*7) A 1 GDF3 (p.E323Q) ATRX p.E545K 3 ATP10B (p.V1277I) 2 GFM2 (p.D131Y) , C p.H1047R

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    1 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us